Canada myocardial infarction market is estimated to grow modestly at a CAGR of around 8.3% during the forecast period. Canada has a considerable market of myocardial infarction treatment due to the presence of a huge patient pool suffering from persisting heart diseases such as CVD, CHD, stroke, hypertension, and other heart diseases. Canada contributes significantly to the MI treatment market due to the huge investment of government in healthcare facilities, R&D, and the adoption of innovative technologies in the healthcare domain. According to the Canadian Institute of Health Research, more than 1.6 million Canadians are suffering from heart disease. It is the second-leading cause of mortality in Canada after cancer. Nine in 10 Canadians over the age of 20 have at least one risk factor involving heart disease. Many health charities invest millions of dollars in research, health promotion, and community programs in Canada. For instance, the Heart and Stroke foundation invested more than $91 million in R&D of heart diseases and surgeries.
Get Free Sample link @ https://www.omrglobal.com/request-sample/canada-myocardial-infarction-market
The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.
A full report of Canada Myocardial Infarction Market available@ https://www.omrglobal.com/industry-reports/canada-myocardial-infarction-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Canada Myocardial Infarction Market by Type
- Non-ST-elevation myocardial infarction (NSTEMI)
- ST-elevation myocardial infarction (STEMI)
- Silent Heart Attacks
Canada Myocardial Infarction Market by Device
- Left Ventricular Assist Device (LVAD)
- Pacemaker
- Catheters
- Implantable Cardioverter-Defibrillator (ICD)
- Others (Stent Graft)
Canada Myocardial Infarction Market by Diagnosis
- Electrocardiography (ECG)
- Chest X-Ray
- Computed Tomography (CT Scan)
- Echocardiography
- Others (Blood Test)
Canada Myocardial Infarction Market by Treatment
- Medication
- Analgesics
- Thrombolytic
- Antiplatelet Agents
- Glycoprotein IIb/IIIa Inhibitors
- Others (Beta-Adrenergic Blockers)
- Surgery
- Angioplasty
- Bypass Surgery
- Heart Transplant
Canada Myocardial Infarction Market by End-Users
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
Company Profiles
- Abbott Laboratories Inc.
- AstraZeneca PLC
- Bayer AG
- Boston Scientific Corp.
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Johnson & Johnson Services, Inc.
- Medtronic PLC
- Merck KGaA
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
The Report Covers
- Comprehensive research methodology of the Canada myocardial infarction market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Canada myocardial infarction market.
- Insights about market determinants which are stimulating the Canada myocardial infarction market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-myocardial-infarction-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
